In what ways does NGS and CGP address the fundamental changes that cancer treatment is undergoing toward the use of molecularly targeted drugs prescribed to patients across tumor types?

In what ways does NGS and CGP address the fundamental changes that cancer treatment is undergoing toward the use of molecularly targeted drugs prescribed to patients across tumor types?

In what important ways does NGS and CGP address the fundamental changes that systemic cancer treatment is undergoing toward the use of molecularly targeted drugs prescribed to patients across multiple tumor types?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Suzhan Zhang, MD

Professor Suzhan Zhang, MD

Director, Cancer Institute
Zhejiang University Multidisciplinary Diagnosis and Treatment Center for Colorectal Cancer
Zhejiang University School of Medicine
Hangzhou, China